Novo Nordisk A/S Increased Operating Profit by 24% in the First Quarter of 2011

BAGSVAERD, DENMARK--(Marketwire - April 28, 2011) -


Organic sales growth of 15% driven by Victoza®, NovoRapid® and Levemir®

Company Announcement no 25 2011: http://hugin.info/2013/R/1509892/444770.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1509892]


Contacts for further information

Media:

Mike Rulis
Tel: (+45) 4442 3573
Email Contact

In North America
Ken Inchausti
Tel: (+1) 609 786 8316
Email Contact

Investors:

Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact

Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact

Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact

In North America
Hans Rommer
Tel: (+1) 609 216 4834
Email Contact

MORE ON THIS TOPIC